Table 4 Survival rates in the subgroups of the study population

Subgroups

n

Survival (%)

p

Demographic characteristics

   Males/Females

779/184

94.5/93.3

0.473

   Age ≥ 65/< 65 years

516/447

92.1/96.7

0.002

Medical history

   Hypertension yes/no

405/558

94.3/94.2

0.927

   Diabetes mellitus yes/no

123/840

94.1/94.3

0.939

   Hypercholesterolemia yes/no

465/498

95.8/92.8

0.069

   Past or current smoking yes/no

491/472

95.3/93.2

0.152

   BMI ≥ 25/< 25 (kg/m²)

619/344

95.0/93.3

0.246

   Family history of MI yes/no

272/691

95.8/93.6

0.209

   Prior MI yes/no

297/666

95.9/93.5

0.179

   Prior PCI yes/no

128/835

96.0/94.0

0.396

   Prior CABG yes/no

89/874

91.9/94.5

0.323

GP III a polymorphism

   A1A1/A1A2/A2A2

690/248/25

95.0/91.8/100.0

0.076

PCI indication

   Stable angina

152

97.3

0.572

   Unstable angina

365

94.3

   MI

282

94.1

   Post MI

117

92.7

   Other

47

93.0

Coronary artery vessels diseased

   Single+two-/three-vessel disease

746/217

94.9/92.1

0.185

LVEF ≥ 40%/< 40%

808/155

95.0/90.5

0.022

Therapy

   ACE inhibitor yes/no

316/647

94.4/94.1

0.886

   Beta-blocker yes/no

546/417

96.0/92.0

0.011

   Statin yes/no

334/629

95.9/93.3

0.114

Revascularisation during follow-up

   PCI yes/no

145/818

99.3/93.4

0.008

   CABG yes/no

29/934

86.1/94.5

0.047

Therapy during follow-up

   Statin yes/no

462/501

96.2/92.5

0.017

   ACE inhibitor yes/no

338/625

100.0/91.1

< 0.001

   Beta-blocker yes/no

580/383

99.8/85.8

< 0.001